| Management Groups |  | |
---|---|---|---|
 | Group A (elevated MWAICP) | Group B (low MWAICP) | Significance |
Demographic | Â | Â | Â |
Patients (n) | 20 (69%) | 9 (31%) | Â |
Age (yrs) | 76 (53 - 84) | 78 (66 - 80) | ns |
Gender (F/M) | 12/8 | 3/6 | ns |
BMI | 24.3 (15.1 - 29.4) | 24.0 (20.0 - 31.3) | ns |
Vascular co-morbidity | Â | Â | Â |
Diabetes | 5 (25%) | 1 (11%) | ns |
Hypertension | 3 (15%) | 3 (33%) | ns |
Cardiovascular | 8 (40%) | 3 (33%) | ns |
Cerebrovascular | 5 (25%) | 2 (22%) | ns |
Cardiac arrhythmia | 3 (15%) | 3 (33%) | ns |
Radiology | Â | Â | Â |
Evan's index | 0.37 (0.30 - 0.44) | 0.38 (0.33 - 0.42) | ns |
Symptoms | Â | Â | Â |
Duration of symptoms (yrs) | 2.0 (0.4 - 10) | 2.0 (0.8 - 6.0) | ns |
Preoperative NPH score | 10 (7 - 13) | 10 (9 - 11) | ns |
Treatment | Â | Â | Â |
Conservative (n) | 1 | 6 | Â |
Shunt (n) | 19 | 3 | Â |
Outcome | Â | Â | Â |
Shunt Non-responders | 3 (16%) | 3 (100%) | Â |
Shunt Responders | 16 (84%) | - | Â |